Results for
"[search-keyword]"
Sponsor content
28 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Samsung Bioepis AU Pty Ltd - Surgical procedure kit, ophthalmic, medicated, single-use.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BYOOVIZ ranibizumab 10 mg/mL solution for injection vial.
-
Australian Public Assessment Report (AusPAR)Byooviz (ranibizumab) for the treatment of neovascular age-related macular degeneration etc.
-
Prescription medicine decision summaryTGA decision: Byooviz (ranibizumab) is approved to treat visual impairment.
-
Prescription medicine registrationActive ingredients: Ranibizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONTRUZANT trastuzumab 150 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HADLIMA adalimumab (rch) 40 mg solution for injection in pre filled syringe.
-
Prescription medicine registrationActive ingredients: adalimumab.